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Abstract
Background: Caesarean section (CS) rates are increasing worldwide and as a result repeat CS is common.
The optimal mode of delivery in women with one previous CS is widely debated and the risks to the infant are
understudied. The aim of the current study was to evaluate if women with a trial of labour after caesarean (TOLAC) had
an increased odds of neonatal and infant death compared to women with an elective repeat CS (ERCS).
Methods: A population register-based cohort study was conducted in Denmark between 1982 and 2010. All women
with two deliveries [in which the first was a CS, and the second was an uncomplicated, term delivery (n = 61,626)] were
included in the study. Logistic regression models were used to report adjusted odds ratios (AOR) and 95% confidence
intervals (CI) of the odds of death according to mode of delivery. The main outcome measures were neonatal death
(early and late) and infant death.
Results: Women with a TOLAC had an increased odds of neonatal death (AOR 1 · 87, 95% CI 1 · 12 to 3 · 12) due to an
increased risk of early neonatal death (AOR 2 · 06, 95% CI 1 · 19 to 3 · 56) and no effect on late neonatal death
(AOR 0 · 97, 95% CI 0 · 22 to 4 · 32), or infant death (AOR 1 · 12, 95% CI 0 · 79 to 1 · 59) when compared to the
reference group of women with an ERCS. There was evidence of a cohort effect as the increased odds of
neonatal death (AOR 3 · 89, 95% CI 1 · 33 to 11 · 39) was most significant in the earlier years (1982–1991) and
gradually disappeared (AOR 1 · 01, 95% CI 0 · 44 to 2 · 31) in the later years (2002–2010).
Conclusions: Although an increased risk of neonatal death was found in women with a TOLAC, there was
evidence of a cohort effect, which showed this increased odds disappearing over time. Advances in modern
healthcare including improved monitoring and earlier detection of underlying pregnancy complications may
explain the findings.
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Background
Caesarean section (CS) rates are increasing worldwide,
and currently CS is the most commonly performed surgi-
cal procedure in women of childbearing age in the United
States (US) [1]. Proposed driving forces include increasing
maternal age at first pregnancy [2], increasing body mass
index (BMI) [3], elective CS for breech presentation and
more recently maternal request for a CS [4, 5], as well
elective repeat CS (in women with a first CS) [ERCS] [6].
Trial of labour after Caesarean section (TOLAC) rates
have decreased significantly in some countries [7], largely
due a reported increased risk of uterine rupture and peri-
natal asphyxia in women undergoing a TOLAC compared
to a planned ERCS [8–11], whilst remaining unchanged in
others [12, 13]. Rising CS rates have generated much
debate on the benefits and risks to the mother and her off-
spring attributable to mode of delivery, particularly
whether or not to attempt a TOLAC in the subsequent
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delivery [14]. Numerous studies have focused on maternal
outcomes reporting an increased risk of uterine rupture,
placenta accreta and placenta previa [15–17]. Evidence
remains to be explored regarding infant outcomes in the
subsequent pregnancy following first CS delivery particu-
larly early and late neonatal death [18, 19]. Controversy
remains on whether a TOLAC or an ERCS is preferable
for women with one prior CS. In the absence of clinical
trials on the topic which are difficult to conduct, popula-
tion register-based research incorporating detailed obstet-
ric information remains the optimum study design to
address this important question.
The objective of the current study was to examine the
odds of neonatal death, early and late neonatal death
and infant mortality in a cohort of women with an
uncomplicated term delivery who had a TOLAC or
ERCS following a first CS.
Methods
Study design, data source and population studied
A cohort study design using the Danish Civil Registration
System (CRS) data was used to identify all women with
their first two deliveries in Denmark between January 1st
1982 and December 31st 2010 (of which the first was a
CS, and the second an ERCS or TOLAC). In order to be
eligible for inclusion in this study the second delivery had
to be an uncomplicated, term delivery (i.e. a singleton,
cephalic delivery between 37 and 42 weeks’ gestation).
After removal of ineligible women and deaths due to
congenital anomalies, there were 61,626 women eligible
for inclusion in the analyses (Fig. 1).
The Danish CRS was established in 1968 originally for
administrative purposes but has since become an invalu-
able source of population-based data for use in epi-
demiological research [20, 21]. The CRS uses a unique
identifier known as the civil person register (CPR) which
enables researchers to link data from different registers
as well as the continuous follow-up of individuals living
in Denmark. For the current study data from the CRS
were linked to the Danish Medical Birth Registry (MBR)
[22, 23], the National Hospital Register (NHR) [24], the
Danish Causes of Death Register [25] and socioeconomic
data were obtained from Statistics Denmark [26] using
the unique CPR number.
Exposure
Mode of delivery was categorised as follows: 1) first CS
and subsequent ERCS [reference group] (n = 20,941), 2)
first CS and subsequent TOLAC (n = 40,685). For the pur-
poses of this study the TOLAC group included any patient
with a previous CS who did not have an ERCS. It therefore
includes patients who have a vaginal birth after Caesarean
(VBAC, i.e. a successful TOLAC) or an emergency CS
(which may have arisen from a failed TOLAC or may have
been done for women with a planned CS who attends in
labour, with ruptured membranes not in labour, etc. and
had an ‘emergency/semi-emergency’ CS). The groups
represent what happens in a real life situation, i.e. ERCS
(planned) versus all other modes of delivery.
Fig. 1 Flowchart of the study population
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Mode of delivery recorded in the Danish registers is
the ‘actual’ mode of delivery (which may differ from the
woman’s intended mode of delivery). For example, a
woman may attempt a TOLAC and fail, ending up with
an emergency CS delivery. In the Danish registries, an
elective CS is defined as a pre-planned (before initiation
of labour) procedure whilst an emergency CS is un-
planned. In this study, we only have information on the
final ‘actual’ mode of delivery recorded in the registry
using the appropriate codes (elective CS DO820; emer-
gency CS DO821).
Main outcome measures
The primary outcome was neonatal death: death of a live
new born within ≤28 days. Secondary outcomes in-
cluded: 1) Early neonatal death: death of a live new born
within ≤7 days; 2) Late neonatal death: death of a live
new born > 7 days ≤ 28 days and 3) Infant death: the
death of a child within ≤365 days.
Statistical analyses
Crude and adjusted logistic regression models were com-
puted to estimate the odds of each outcome in women
with a TOLAC compared to women with an ERCS using
crude odds ratios (ORs) or adjusted ORs (AORs) and 95%
confidence intervals (CIs). Adjusted models were a priori
defined as follows:
Model 1: key potential confounders available for the
entire study period from the second live birth including
maternal age, country of origin, educational attainment,
mother and father’s gross income, marital status, infant
birthplace, infant birth weight, birth year and history of
pregnancy loss (1982–2010, cohort n = 61,626).
Testing for a cohort effect
In order to test for the cohort effect and temporal
changes over time, the cohort was split into three differ-
ent time periods (1982–1991, 1992–2001, 2002–2010)
and the analyses repeated.
Subgroup and sensitivity analyses
A subgroup analysis restricted to women delivering be-
tween 38 and 40 weeks’ gestation was conducted to in-
vestigate the effect of gestational age on the outcomes
of interest in overdue or induced pregnancies with a
TOLAC. In addition, data for smoking, co-morbidities
and BMI were only available for specific time periods.
Sensitivity analyses were conducted restricting the co-
hort to the specific time periods for which data were
available on smoking, co-morbidities and BMI (with
and without adjusting for these covariates).
Model 1: adjusted for key potential confounders
available for the entire study period including maternal
age, country of origin, educational attainment, mother
and father’s gross income, marital status, infant
birthplace, infant birth weight, birth year and history
of pregnancy loss plus smoking status (1991–2010,
cohort n = 50,880).
Model 2: adjusted for Model 1 plus comorbidities in
the second live birth including hypertension, eclampsia,
preeclampsia, fetal distress and gestational diabetes
(1994–2010, cohort n = 45,979).
Model 3: adjusted for Model 2 plus BMI
(2004–2010, cohort n = 22,672).
Where a variable had missing data, the variable was
re-coded to include missing data as a separate category
(for example, for maternal smoking, 1 = smoker, 2 = non-
smoker, 3 =missing) and included in the various
analyses. As outlined by Vach and Blettner, adding miss-
ing data as a separate category where the proportion of
missing data is small (as in this study) should not im-
pact greatly on the effect estimates [27]. All analyses
were conducted using SAS© version 9.4 software (SAS
Institute, Inc., Cary, NC, USA) and the PROC LOGISTIC
[28] command. Approval to use the data was obtained
from the Danish National Board of Health and Statistics
Denmark for the current study.
Results
Characteristics of the study population
The study included 61,626 women with at least two live
births. These women were subdivided into 40,685
women with a TOLAC (66%), and 20,941 (34%) women
with an ERCS, (Fig. 1). Maternal characteristics of the
study group are outlined in [Table 1] and infant charac-
teristics are outlined in [Table 2].
The rate of successful TOLAC (VBAC) did not vary
significantly over the entire study period ranging from 5
to 8% (see Additional file 1).
Neonatal death, early neonatal death, late neonatal death
and infant death
Neonatal death (≤28 days): An increased odds of neo-
natal death was found in women with a TOLAC (AOR
1 · 87, 95% CI 1 · 12, 3.12) compared to the reference
group of women with an ERCS. Early neonatal death
(≤7 days after birth): Compared to the reference group
of women with an ERCS, women with a TOLAC had
more than twice the odds of early neonatal death (AOR
2 · 06, 95% CI 1 · 19, 3 · 56), (see Table 3).
Late neonatal death (>7 days, ≤ 28 days after birth):
Compared to the reference group, women with a
TOLAC had no increased odds of late neonatal death
(AOR 0 · 97, 95% CI 0 · 22, 4 · 32). Infant death (≤365 days
after birth): There was no association (AOR 1.12, 95%
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Table 1 Maternal characteristics in the second live birth in Denmark, 1982–2010
First CS
Elective repeat CS Trial of labour after CS Total
Maternal characteristics of the second delivery
Age in years, <20 24 (0%) 133 (0%) 157 (0%)
20–25 1,920 (9%) 5,655 (14%) 7,575 (12%)
26–30 6,997 (33%) 16,582 (41%) 23,579 (38%)
31–35 8,096 (39%) 14,349 (35%) 22,445 (36%)
36–40 3,423 (16%) 3,660 (9%) 7,083 (11%)
41+ 481 (2%) 306 (1%) 787 (1%)
Origin, Denmark 18,685 (89%) 36,757 (90%) 55,442 (90%)
Other 2,183 (10%) 3,834 (9%) 6,017 (10%)
Unknown 73 (0%) 94 (0%) 167 (0%)
Marital status, Married 7,514 (36%) 13,567 (33%) 21,081 (34%)
Divorced/separated/widowed 573 (3%) 748 (2%) 1,321 (2%)
Co-habiting 12,633 (60%) 25,917 (64%) 38,550 (63%)
Unknown 221 (1%) 453 (1%) 674 (1%)
Educational attainment, Primary 4,496 (21%) 9,817 (24%) 14,313 (23%)
High school 10,193 (49%) 20,057 (49%) 30,250 (49%)
Third level degree 4,183 (20%) 7,432 (18%) 11,615 (19%)
Masters/PhD 1,447 (7%) 2,183 (5%) 3,630 (6%)
Unknown 622 (3%) 1,196 (3%) 1,818 (3%)
Mother’s gross income (quartiles), 25 2,997 (14%) 5,766 (14%) 8,763 (14%)
50 3,954 (19%) 7,789 (19%) 11,743 (19%)
75 9,513 (45%) 19,299 (47%) 28,812 (47%)
100 4,339 (21%) 7,514 (18%) 11,853 (19%)
Unknown 138 (1%) 317 (1%) 455 (1%)
aSmoker, No 14,387 (82%) 25,814 (78%) 40,201 (79%)
Yes 2,665 (15%) 6,733 (20%) 9,398 (18%)
Unknown 566 (3%) 715 (2%) 1,281 (3%)
Characteristic of the second delivery
Father’s gross income (quartiles), 25 1,497 (7%) 3,156 (8%) 4,653 (8%)
50 2,264 (11%) 4,765 (12%) 7,029 (11%)
75 6,266 (30%) 12,702 (31%) 18,968 (31%)
100 10,582 (51%) 19,412 (48%) 29,994 (49%)
Unknown 332 (2%) 650 (2%) 982 (2%)
bBMI (kg/m2) <18.5 523 (5%) 638 (5%) 1,161 (5%)
18.5–25 5,849 (55%) 7,412 (62%) 13,261 (58%)
26–30 2,198 (21%) 2,092 (18%) 4,290 (19%)
31–35 1,064 (10%) 753 (6%) 1,817 (8%)
36+ 643 (6%) 347 (3%) 990 (4%)
Unknown 439 (4%) 714 (6%) 1,153 (5%)
cPreeclampsia, eclampsia 342 (2%) 613 (2%) 955 (2%)
dFetal distress 98 (1%) 6,358 (22%) 6,456 (14%)
eGestational diabetes 645 (4%) 504 (2%) 1,149 (3%)
fHypertension 203 (1%) 337 (1%) 540 (1%)
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CI 0.79, 1.59) between women with a TOLAC and infant
death compared to women with an ERCS (see Table 3).
Testing for a cohort effect
To test for the cohort effect, the cohort was split into
three time periods. The increased odds of neonatal death
among women with a TOLAC was greatest in the earliest
years (1982–1991) with an AOR of 3 · 89 (95% CI 1 · 33,
11 · 39) compared to women with an ERCS (see Table 4).
This decreased over time to an AOR of 2 · 87 (95% CI
0 · 85, 9 · 70) between 1992 and 2001, and disappeared in
the most recent years of 2002–2010 (AOR 1 · 01, 95% CI
0 · 44, 2 · 31). This decreasing trend is displayed graphic-
ally (see Fig. 2).
Subgroup and sensitivity analyses
A subgroup analysis restricted to include women deliver-
ing between 38 and 40 weeks was conducted to assess
the effect of gestational age on overdue or induced
women with a TOLAC compared to the reference group
of women with an ERCS (see Additional file 2). Women
with a TOLAC had an increased odds of neonatal death
(AOR 1 · 78, 95% CI 1 · 03, 3 · 08) and early neonatal
death (AOR 1 · 99, 95% CI 1 · 11, 3 · 58). No association
was found for late neonatal death (AOR 0 · 71, 95% CI
0 · 13, 3 · 76) or infant death (AOR 1 · 11, 95% CI 0 · 76,
1 · 63) in women with a TOLAC compared to women
with an ERCS (see Additional file 2). Further sensitivity
analyses were conducted restricting the cohort to the
specific time period for which certain covariates were
available (smoking, co-morbidities, BMI) but without
adjusting for them specifically. For example, smoking
data were available from 1991 to 2010 and the cohort
was restricted to this time period without adjustment
for the effects of smoking. The increased risk of
neonatal death overall disappeared in these additional
analyses, but did not explain the overall findings (see
Additional files 3 and 4).
Discussion
Main findings
In the present study the odds of delivery-related neo-
natal and infant death were assessed in a large cohort of
more than 61,000 women. We found evidence of a co-
hort effect over time, where in the earliest years the in-
creased odds of neonatal death were greatest (over three
times higher than that of the women with an ERCS),
gradually disappearing over time. Post-hoc analyses sum-
marising the case-mix of TOLAC women according to
cohort time were conducted (see Additional file 5).
Overall, there was no change in the percentage of
women having a TOLAC across the study period as well
as in the characteristics of these women including age,
educational attainment, gross income and origin.
Advances in obstetrics and changes in practice, as well
as perhaps changes in the women having a TOLAC are
some of the driving forces behind this finding, meaning
that the neonatal death rate is now not significantly
different with TOLAC, making it a reasonable choice for
pregnant women. We found no increased odds of late
neonatal death or infant death. It must be acknowledged
however that there were only six late neonatal deaths in
women with a TOLAC. The association disappeared in
additional adjusted analyses accounting for smoking, co-
Table 1 Maternal characteristics in the second live birth in Denmark, 1982–2010 (Continued)
Previous stillbirth 494 (2%) 371 (1%) 865 (1%)
Previous miscarriage 3,288 (16%) 6,675 (16%) 9,963 (16%)
Previous ectopic pregnancy 863 (4%) 1,681 (4%) 2,544 (4%)
Data are n (%).aSmoking data available from 1991 to 2010 (cohort n = 50,880). bBMI: Body mass index, data available from 2004 to 2010 only (cohort n = 22,672).
c, d, e, f, Preeclampsia, eclampsia; fetal distress; gestational diabetes, hypertension: data available from 1994 to 2010 (cohort n = 45,979). CS Caesarean section
Table 2 Infant characteristics in the second live birth in
Denmark, 1982–2010
Infant characteristics of the
second delivery
First CS
Elective repeat CS Trial of labour
after CS
Infant sex, male 10,845 (52%) 20,472 (50%)
Female 10,096 (48%) 20,213 (50%)
Birthplace, Capital (Copenhagen) 3,809 (18%) 6,352 (16%)
Capital suburbs 2,224 (11%) 5,409 (13%)
Provincial city 2,641 (13%) 4,852 (12%)
Provincial town 5,846 (28%) 11,184 (27%)
Rural area 6,369 (30%) 12,807 (31%)
Unknown 52 (0%) 81 (0%)
Apgar score <7 at 5 min 190 (1%) 1,016 (3%)
Birth weight (g), <2,500 1,440 (7%) 6,165 (15%)
2500–3500 8,179 (39%) 18,805 (46%)
3500–4500 9,556 (46%) 14,358 (35%)
4500+ 1,569 (7%) 1,129 (3%)
Unknown 197 (1%) 228 (1%)
Gestational age, weeks,
mean ± standard deviation
39.06 (1.2) 40.28 (1.3)
Admission to NICUa 645 (5%) 414 (3%)
Data are n (%) or mean ± standard deviation unless otherwise stated. CS
Caesarean section, NICU Neonatal intensive care unit. aAdmission to NICU: data
available from 2002 to 2010 (n = 27,868)
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morbidities and BMI, suggesting that generally safety is
improving and that better case selection is vital and
could make TOLAC even safer. When the cohort was
restricted to include women with term deliveries (38–40
weeks gestation), the findings remained the same.
The improved safety in terms of outcomes follow-
ing TOLAC could be for a multitude of reasons in-
cluding improvements in CS as an abdominal surgery
(for example changes in uterine incision which came
into effect in Denmark) and advances in the diagno-
sis and management of pregnancy and pregnancy-
related co-morbidities. Confounding by indication for
underlying medical conditions may also explain the
increased odds of early neonatal death found in
women with a TOLAC due to acute events during
delivery for example.
Strengths and limitations
Our study used population-based registry data which are
regularly updated and validated for epidemiological re-
search. The unique CPR identifier enables accurate
linkage between the various registers and as a result
detailed obstetric data were available for the current
study allowing us to adjust for a large number of clinical
Table 3 Neonatal death and infant death according to mode of delivery in a Danish cohort, 1982–2010
Mode of delivery 1st and 2nd birth
(Number of events)
Neonatal death (≤28 days) n = 95
OR (95% CI) aModel 1 AOR (95% CI)
CS – ERCS (n = 21) Ref Ref
CS – TOLAC (n = 74) 1.82 (1.12, 2.95) 1.87 (1.12, 3.12)
Mode of delivery 1st and 2nd birth
(Number of events)
Early neonatal death (≤7 days) n = 86
OR (95% CI) aModel 1 AOR (95% CI)
CS – ERCS (n = 18) Ref Ref
CS – TOLAC (n = 68) 1.95 (1.16, 3.27) 2.06 (1.19, 3.56)
Mode of delivery 1st and 2nd birth
(Number of events)
Late neonatal death (>7 days, ≤28 days) n = 9
OR (95% CI) aModel 1 AOR (95% CI)
CS – ERCS (n = 3) Ref Ref
CS – TOLAC (n = 6) 1.03 (0.26, 4.12) 0.97 (0.22, 4.32)
Mode of delivery 1st and 2nd birth
(Number of events)
Infant death (≤365 days) n = 171
OR (95% CI) aModel 1 AOR (95% CI)
CS – ERCS (n = 49) Ref Ref
CS – TOLAC (n = 122) 1.28 (0.92, 1.79) 1.12 (0.79, 1.59)
Data are crude and adjusted odds ratios with 95% confidence intervals. OR odds ratio, AOR adjusted odds ratio, CI confidence interval, ERCS Elective repeat
caesarean section, TOLAC Trial of labour after caesarean section
aModel 1: adjusted for key covariates in the second birth including maternal age, maternal country of origin, educational attainment, mother and father’s gross
income, marital status, infant birthplace and infant birth weight, history of pregnancy loss and birth year (cohort n = 61,626)
Table 4 Neonatal death and infant death according to mode of delivery by time period (cohort effect)
Mode of delivery 1st and 2nd births Neonatal death (≤28 days) n = 95 in entire cohort 1982–2010
aModel 1 AOR (95% CI)
(35 deaths)
bModel 2 AOR (95% CI)
(34 deaths)
cModel 3 AOR (95% CI)
(26 deaths)
CS – ERCS Ref Ref Ref
CS – TOLAC 3.89 (1.33, 11.39) 2.87 (0.85, 9.70) 1.01 (0.44, 2.31)
Mode of delivery 1st and 2nd birth Infant death (≤365 days) n = 171 in entire cohort 1982–2010
aModel 1 AOR (95% CI)
(69 deaths)
bModel 2 AOR (95% CI)
(64 deaths)
cModel 3 AOR (95% CI)
(38 deaths)
CS – ERCS Ref Ref Ref
CS – TOLAC 1.24 (0.70, 2.21) 1.37 (0.70, 2.69) 0.81 (0.42, 1.59)
Data are adjusted odds ratios with 95% confidence intervals. AOR adjusted odds ratio, CI confidence interval, ERCS Elective repeat caesarean section, TOLAC Trial
of labour after caesarean
aModel 1: Cohort restricted to first time period (1982–1991, cohort n = 11,698) and adjusted for key covariates in the second birth including maternal age,
maternal country of origin, educational attainment, mother and father’s gross income, marital status, infant birthplace and infant birth weight, history of
pregnancy loss and birth year
bModel 2: Cohort restricted to second time period (1992–2001, cohort n = 22,060) and adjusted for key covariates as in Model 1
cModel 3: Cohort restricted to last time period (2002–2010, cohort n = 27,868) and adjusted for key covariates as in Model 1
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and demographic potential confounders. The cohort in-
cluded more than 61,000 women and spanned almost
three decades. Therefore, we were also able to test for
evidence of a cohort effect over time. We focused on
infant mortality as most of the research to date has
prioritised outcomes for mothers.
Limitations to this study and the majority of studies
conducted prior to this include that we only have
data on the actual mode of delivery recorded rather
than the ‘planned’ mode of delivery. Although ‘mater-
nal request for a CS’ has been recorded in the Danish
registry data since 2002, the number of neonatal
deaths was too few in this subgroup to assess whether
any association exists in the data. Clinical trials will
likely not be forthcoming as women will decline to be
randomised according to mode of delivery. Therefore,
large-scale observational studies like the current study
detailed here remain the best way to study the effects
of mode of delivery on subsequent pregnancy out-
comes. In addition, we did not have access to data on
type of stillbirth (antepartum or intrapartum). This
calls for more delicate registrations of events and
series of events, indications and procedures, etc. re-
lated to reproduction, pregnancy and delivery to
enable more detailed analyses of potential associations
between e.g. procedures such as CS and adverse
events. The study was also carried out using registry
data that contain no specific information on the
clinical indication for CS. We tried to reduce this
problem by adjusting for a number of medical condi-
tions but this could not cover all possible indications.
In addition to this, data were only available for cer-
tain covariates for specific time periods as outlined
earlier. Unmeasured confounders are also a limitation
of this study and all observational studies.
Interpretation
Our findings are in contrast to a previous study con-
ducted in Scotland [29] which found that women with a
first CS undergoing a TOLAC had 11 times the odds of
delivery-related perinatal death (AOR 11 · 7, 95% CI 1 ·
4–101 · 6) compared to women with an ERCS. The con-
fidence intervals reported in the Scottish study are very
broad and must be interpreted with caution. Further-
more, the Scottish study included intrapartum stillbirths
and did not adjust for medical conditions in addition to
BMI as was the case in the current study. The first and
only nested randomised control trial (RCT) to date
which divided women according to patient preference
(n = 2,323) or randomisation (n = 22) to planned TOLAC
or planned ERCS found that among women with one
prior CS, planned ERCS compared with planned TOL
was associated with a lower risk of fetal death and infant
death or serious infant outcome (relative risk [RR] 0 · 39,
95% CI 0 · 19–0 · 80) [30]. Although strengthened by the
process of randomisation, very few women actually
consented to randomisation.
Ideally further research into the effect of mode of
delivery on subsequent pregnancy outcome should in-
corporate a woman’s ‘intended’ mode of delivery. This is
the best way to assess any risks as one would know
whether or not a woman was truly eligible to attempt a
TOLAC. RCTs would be the optimal method of answer-
ing this question however they are difficult to conduct
as it is hard to randomise a woman according to mode
of delivery and unfeasible for rare outcomes such as
perinatal death. Currently however, large population-
based data such as the Danish registry data used in this
study are the best methods for assessing the effects of
mode of delivery and there is a continuous call for im-
provements in the quality and amount of data collected.
Fig. 2 Odds ratio of neonatal death in the trial of labour after caesarean section (TOLAC) group
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Conclusions
There are benefits and harms associated with each
mode of delivery and the evidence for this is drawn
from observational (non-randomised) research studies
that may be prone to bias. Any results and conclu-
sions must be interpreted with caution although
large-scale population-based studies including the
present one offer the best method of estimating the risks
in women with one prior CS in the absence of RCTs. Our
data provide essential, up to date information for expect-
ant parents as well as healthcare workers to make a more
informed decision regarding TOLAC.
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